Combined drug and CRISPR/CAS9 screening reveals specific targets for SF3B1- and NOTCH1- mutated CLL cells.

• Authors: DOSTÁLOVÁ Lenka; LADUNGOVÁ Adriana; ŠKRNOVÁ Dominika; GOTTUMUKKALA Narendra Varma; LODHI Yusuf; ŠMÍDA Michal
• Year of publication: 2022
• Type: Conference abstract
• MU Faculty or unit: Central European Institute of Technology

Related projects

• Genome-wide CRISPR/Cas9 screening to identify novel therapeutical targets for NOTCH1 and SF3B1 mutated B-cell chronic lymphocytic leukemia
• Specifický výzkum v oblasti „Life Sciences“
• Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit IX